Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2023 Earnings Call Transcript February 7, 2023
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal First Quarter Ended December 31, 2022 Financial Results Conference Call. At this time all participants are in a listen only mode. Please be advised that today’s conference is being recorded. I’d now like to hand the conference over to Jennifer Viera, Investor Relations. Please go ahead.
Jennifer Viera: Thank you, operator, and...
